Dr. Shella Saint Fleur-Lominy, MD, PhD, is a hematology and oncology physician-scientist and Associate Professor at the University of Maryland School of Medicine. She is a member of the Cancer Therapeutics Program at the University of Maryland Greenebaum Comprehensive Cancer Center and serves as Associate Graduate Faculty in the Molecular Medicine Program at the University of Maryland School of Graduate Studies. Clinically, she focuses on hematologic malignancies, myeloid neoplasms, and cancer therapeutics. Her research centers on gene expression regulation in hematologic cancers, epigenetic and cell-signaling mechanisms underlying oncogenesis and treatment resistance, and advancing health equity through inclusive clinical trials. Her leadership includes serving as Program Director of the Hematology and Medical Oncology Fellowship at NYU Langone Health, course director and lecturer roles, and former membership on the ASCO Oncology Training Program Committee. She earned her MD and a PhD in Molecular Oncology and Immunology from New York University, completed residency in Internal Medicine at NYU, and pursued fellowship training in Hematology and Medical Oncology at NYU.
Associate Professor
Medical School
2010
Residency
2010 – 2012
Fellowship
2017